LRRK2 and malignant colon neoplasm: As mentioned early, Takagawa T, et al. [47] found that LRRK2 gene overexpression promotes DSS-induced colitis; therefore, as an important future direction, it is imperative to explore whether this overexpression can also promote colitis-associated cancer, and if colon cancer patients have increased expression of LRRK2.